–
Xilio Therapeutics, Inc.
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25
(positive)
millions USD
FY21:
FY22:
–
FY23:
0
FY24:
–
FY25:
–
(positive)
Change from FY21 to FY25
millions USD
FY21:
−75.0
FY22:
−89.1
FY23:
−79.1
FY24:
−60.6
FY25:
−42.0
(positive)
Change from FY21 to FY25
millions USD
FY21:
−73.5
FY22:
−87.3
FY23:
–
FY24:
–
FY25:
−46.3
(positive)
Change from FY21 to FY25
millions USD
FY21:
−75.8
FY22:
−88.2
FY23:
–
FY24:
−58.2
FY25:
−35.0
(positive)
Change from FY21 to FY25
millions USD
FY21:
−75.8
FY22:
−88.2
FY23:
−76.4
FY24:
−58.2
FY25:
−35.0
All amounts in millions USD